Bis(pivaloyloxymethyl) thymidine 5'-phosphate is a cell membrane-permeable precursor of thymidine 5'-phosphate in

Saeed R Khan1, Billie Nowak, William Plunkett

  • 1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA. khansa@jhmi.edu

Insights

Bis(pivaloyloxymethyl) thymidine 5-phosphate (POM(2)-dTMP) effectively inhibits cell growth in both normal and thymidine kinase-deficient cells. This membrane-permeable prodrug serves as a viable source of thymidine monophosphate (dTMP).

Area of Science:

  • Pharmacology
  • Cell Biology
  • Biochemistry

Background:

  • Thymidine (TdR) is crucial for DNA synthesis but requires thymidine kinase (TK) for activation.
  • TK-deficient cells exhibit resistance to TdR, limiting its therapeutic applications.
  • Developing membrane-permeable prodrugs of thymidine monophosphate (dTMP) is essential for overcoming TK deficiency.

Purpose of the Study:

  • To evaluate bis(pivaloyloxymethyl) thymidine 5-phosphate (POM(2)-dTMP) as a prodrug of dTMP.
  • To compare the growth inhibitory activity of POM(2)-dTMP and TdR in wild-type and TK-deficient CCRF CEM cells.
  • To investigate the mechanism of POM(2)-dTMP uptake and its conversion to dTMP.

Main Methods:

  • Cell culture of wild-type (CEM) and TK-deficient (CEM tk-) CCRF CEM cells.
  • Antiproliferative assays to determine IC(50) values for POM(2)-dTMP and TdR.
  • Radiolabeling studies using [methyl-(3)H]dTMP and [methyl-(3)H]TdR to assess cellular uptake and incorporation.

Main Results:

  • POM(2)-dTMP exhibited significant and equal growth inhibition (IC(50)=5 microM) in both CEM and CEM tk- cells.
  • TdR showed potent activity against CEM cells (IC(50)=27 microM) but weak activity against CEM tk- cells (IC(50)=730 microM).
  • CEM tk- cells incorporated radioactivity from POM(2)-dTMP into acid-insoluble residue at a substantial rate, unlike with TdR.

Conclusions:

  • POM(2)-dTMP effectively bypasses the requirement for thymidine kinase.
  • This prodrug demonstrates efficient cellular penetration and serves as a valuable source of dTMP.
  • POM(2)-dTMP holds potential as a therapeutic agent for conditions involving TK deficiency.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.